OBJECTIVE: Patients undergoing transapical aortic valve implantation (TA-AVI) are usually over 80 years old and have a high prevalence of chronic kidney disease. However, transcatheter valve therapies require the use of contrast injections with the risk of nephrotoxicity. The aim of this study was to evaluate post-operative kidney function and survival in patients with pre-existing renal impairment with regard to the amount of contrast media used during TA-AVI.
INTRODUCTION
Transcatheter aortic valve implantation (TAVI) is an emerging procedure in cardiovascular medicine for high-risk patients with severe aortic stenosis who are not ideal candidates for traditional open heart surgery. Over the years, TAVI using transfemoral or transapical access has become an established procedure performed worldwide in highly qualified cardiac centres, with satisfactory short-and mid-term results. However, this newly developed technique includes the need of fluoroscopy and angiography using a contrast agent for the identification of specific cardiac landmarks for the stent-valve positioning. Unfortunately, as a consequence of this approach all patients are exposed to an extensive and multiple use of contrast injections with a certain risk of contrast-induced nephropathy (CIN). CIN is the third most common cause of acute renal failure and is associated with increased morbidity and in-hospital mortality [1] . Recent reports have confirmed that the incidence of renal disorders after TAVI can rise to 30% with, sometimes, transitory or permanent dialysis [2] , and this phenomenon is amplified when concomitant comorbidities affect negatively the renal revascularization and function.
Despite the fact that TAVI is an easily available and commonly used treatment option for patients with severe aortic stenosis not eligible for surgery, data concerning the effect of contrast media on renal function are scarce [3] . It is proposed that CIN correlates with the use of increasing contrast volumes during TAVI. This assumption has led to the current recommendation to limit the dose of contrast in patients at high risk for renal dysfunction. On the other hand, limits in contrast dosing may negatively impact the precise visualization of landmarks for the stent-valve positioning in the ideal landing zone.
Therefore, the aim of the present study was to retrospectively assess CIN and death in patients with pre-existing renal impairment with respect to the amount of a contrast agent used during transapical aortic valve implantation (TA-AVI).
MATERIALS AND METHODS

Patient characteristics and inclusion criteria
A total of 144 patients diagnosed with symptomatic severe aortic stenosis underwent TA-AVI at our institution between February 2008 and March 2011. Patients on chronic haemodialysis (n = 10), those who died within 24 h precluding creatinine measurements following TA-AVI (n = 5) and those with a pre-operative normal kidney function [ pre-operative serum creatinine level <1.3 mg/dl and estimated glomerular filtration rate (eGFR) >60 ml/min/1.73 m 2 ; n = 79] were excluded from the study, leading to a final study population of 50 patients. These patients were divided into two groups according to the amount of a contrast agent used during the procedure:
Low-dose group: 24 patients receiving a dose of up to 100 ml of a contrast agent; High-dose group: 26 patients receiving a dose >100 ml of a contrast agent.
The primary endpoint of this study was the renal outcome; the secondary endpoints included 30-day, 3-month and 3-year mortality.
Prosthetic valve system and procedure
The patients accepted for TA-AVI were selected by a clinical committee consisting of cardiologists and cardiac surgeons of our department, estimating the frailty in combination with the pre-operative cardiac status in combination with pre-existing comorbidities and therefore the risk profile of the patients individually. In preparation for TA-AVI, coronary anatomy was assessed by coronary angiography in all patients. Pre-procedural native computed tomography (CT) scans were performed only in patients with previous cardiac surgery (n = 10) to define the retrosternal region for an eventual urgent sternotomy.
The implanted prosthetic valve system consists of a pericardial xenograft fixed in a balloon-expandable stent of stainless steel (SAPIEN THV; Edwards Lifesciences, Irvine, CA, USA). All patients received 23, 26 or 29 mm external diameter prosthesis, depending on their echocardiographically measured annulus diameters. The injected contrast agent was Accupaque (Amersham Health AG, Waedenswil, Switzerland), a contrast medium containing iodine and iso-osmolar contrast medium (1 ml contains 647 mg iohexol).
Contrast-induced nephropathy definition
In each patient, the eGFR according to modification of diet in renal disease formula was measured 1 day before and 1-7 days after the procedure. The CIN was defined as a serum creatinine increase of 0.5 mg/dl or by >25% of the baseline value within 48 h from contrast medium administration with the absence of alternative aetiology [4] . Serum creatinine levels were followed up from the day prior to TA-AVI daily till the 7th post-operative day. Dialysis therapy was initiated by the attending nephrologists based on the clinical experience, serum potassium, urea levels and urine output. For the prevention of contrast-induced renal failure, all patients received intravenous normal saline 1 day prior to procedure (100 ml/h, at least 4 h before the procedure) and continued for 24 h. Intravenous N-acetylcysteine at a dose of 1200 mg/day was also administered. In diabetic patients, metformin was withdrawn at least 1 day prior to TA-AVI.
Data collection and patient demographics
Data such as demographics, clinical characteristics, comorbid conditions, medical treatments, laboratory data, angiographic data (including the amount and the type of contrast used during TA-AVI) and peri-and post-operative events were routinely collected in a computerized database for all patients undergoing TA-AVI at our institution prospectively. We used these existing data for our analysis.
Statistical analysis
Statistical analysis was performed using StatsDirect (StatsDirect Ltd, Cheshire, UK) and SPSS statistical software packages (SPSS Inc., Chicago, IL, USA). Continuous variables were compared using the unpaired t-test for parametric variables (in the case of the Gaussian distribution by visual inspection) or the MannWhitney U-test for non-parametric variables (no Gaussian distribution by visual inspection), respectively. Descriptive statistics for categorical data of groups were compared with the Fisher's exact test. Data were expressed in dependency on the test used as the mean ± SD ( parametric), median and 25th and 75th percentiles (non-parametric) or number (n) and percent (%) (categorical data), whereas figures represent the mean ± standard error of mean.
Univariate and multivariate logistic regression analyses of relevant variables were performed to identify predictors for a 30-day survival and CIN. All variables with a P-value of <0.2 by means of univariate regression were entered into a backward, stepwise, binary logistic regression model. Only those variables significant at a two-tailed nominal P < 0.05 were retained within the model. Odds ratios and corresponding 95% confidence intervals are reported, and P-values of <0.05 were considered to be statistically significant. Variables entered into the predictive model were male gender, age >80 years, body mass index >30 kg/m 2 , numeric and logistic European system for cardiac operative risk evaluation (EuroSCORE) >10 or 30%, Society of Thoracic Surgeons (STS) score >20, left ventricular ejection fraction <40%, haemoglobin >10 g/dl, coronary artery disease, urgent surgery, New York Heart Association (NYHA) class III-IV, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, peripheral vascular disease, renal dysfunction (creatinine >2.0 mg/dl), eGFR >60 ml/min/1.73 m 2 , pre-operative coronary angiography and CT, duration of operation >120 min, contrast media volume >100 ml, CIN, haemodialysis, RBC transfusion, re-thoracotomy, intensive care unit (ICU) stay >72 h and hospital stay >10 days.
RESULTS
Overall group
Baseline clinical characteristics of the study population and the main TA-AVI peri-procedural characteristics according to the amount of contrast media are shown in Tables 1 and 2 . TA-AVI was performed in 50 patients with pre-existing renal impairment [1.62 (1.3-1.94) mg/dl]. The mean age of the patients was 80.7 ± 5.3 years with 24 (48%) males and 26 (52%) females. Fifty-six percent (n = 28) of patients enrolled in this study were diabetic, 80% (n = 40) were hypertensive and 88% (n = 44) were in NYHA class III-IV. Mortality risk as estimated by the logistic EuroSCORE and the STS score was 32.7 ± 19.6 and 20.2 ± 8.6%, respectively. The mean volume of contrast material administered was 113.1 ± 60.1 ml.
The contrast-induced reduction in renal function occurred in 56% (n = 28) of patients. The frequency of CIN with a need for renal replacement therapy was significantly higher in women than in men [n = 3 (12.5%) in men vs. n = 11 (73.3%) in women, P = 0.028]. The percentage decrease in eGFR 48 h after TA-AVI was 30% (48-14%) in the overall group. Twenty-eight percent (n = 14) required dialysis. Analysis of the post-operative morbidity in terms of the length of ICU stay and the complete length of hospital stay were 4 (3-7) and 12 (9-16.7) days. The 30-day, 3-month and 3-year mortality were 18 (n = 9), 20 (n = 10) and 44% (n = 22), respectively.
Comparison between low-and high-dose groups
Patients in both groups (low-dose group, n = 24; high-dose group, n = 26) had similar characteristics in terms of age, sex and body mass index (Table 1) . Patients in the high-dose group had a significant higher numeric EuroSCORE (10.9 ± 3.0 vs. 13.0 ± 2.8, P = 0.02) and higher prevalence of coronary artery disease (45.9 vs. 76.9%, P = 0.023). In the low-dose group, the mean volume of a contrast agent administered was 71.2 ± 23.4 ml, whereas in the high-dose group, it was 151.8 ± 57.7 ml (P < 0.0001). Comparisons of serum creatinine and eGFR values before and after the administration of the contrast agent for 7 days are given in Figs 1 and 2. The mean pre-contrast creatinine in the low-contrast group was 1.67 (1.37-1.83) mg/dl and the high-dose group was 1.51 (1.26-1.98) mg/dl (P = 0.76, insignificant). The post-contrast creatinine at 48 h was 1.53 (1.33-2.05) mg/dl and 2.29 (1.67-2.86) mg/dl in the groups receiving low-and high-dose contrast agents, respectively (P = 0.003). The percentage changes in eGFR at 48 h following TA-AVI in the two groups are shown in Fig. 3 . CIN occurred in 41.7% in the low-dose group (66.7% in female) and in 69.2% (71.4% in female) in the high-dose group (P = 0.046). Four of the 24 patients in the low-dose group (16.7%) and 10 of the 26 patients in the high-dose group (38.5%) required dialysis during index hospitalization (P = 0.12, insignificant).
Analysis of the serum lactate levels revealed a significant elevation in both groups after TA-AVI (P < 0.05) when compared with post-operative day 1. However, although post-operative mean plasma lactate concentrations in the high-dose group were higher, the difference was not statistically significant (P > 0.05). 
ADULT CARDIAC
Regarding peri-procedural blood transfusions, patients in the high-dose group received more frequently blood units without reaching statistical significance [3 (2-7) vs. 2 (2-4) units, P = 0.331].
Analysis of the post-operative morbidity in terms of ICU length of stay and the complete length of hospital stay revealed no significant difference between the two groups. However, trends towards slightly longer ICU and hospital stay were seen in patients with an extensive use of contrast media [4.3 (2.5-6.5) vs. 5 (3-7.8) days and 12 (9-14.25) vs. 13 (9-18) days, respectively].
Regarding death, 30-day mortality was not significantly different between the groups with 8.3% (n = 2) in the low-dose group and 30.8% (n = 8) in the high-dose group (P = 0.068). However, in the long term, 3-month and 3-year mortality were significantly higher in the high-dose group (8.3 vs. 30.8% and 25 vs. 61.5%, respectively).
Univariate and multivariate analyses
Univariate logistic regression analysis revealed a possible association of CIN with the amount of contrast media (P = 0.182), eGFR (P = 0.187), chronic obstructive pulmonary disease (P = 0.058), diabetes mellitus (P = 0.034), re-thoracotomy (P = 0.111) and blood transfusion (P = 0.133).
The small number of studied patients limited the possibilities for extensive multivariate regression analysis. Nevertheless, combining all the above-mentioned variables into a multivariate logistic regression model and using a stepwise selection revealed that CIN was definitively related to the chronic obstructive pulmonary disease and blood transfusion (Table 3) . On multivariate analysis, an extensive use of contrast media showed a trend (P = 0.09) towards increased CIN. Accordingly, a 30-day mortality univariate logistic regression analysis revealed a possible association with numeric EuroSCORE >10 (P = 0.168), hypertension (P = 0.088), coronary artery disease (P = 0.037), duration of operation >120 min (P = 0.177) and haemodialysis (P = 0.049). By multivariate analysis, hypertension, coronary artery disease and haemodialysis were identified as independent predictors of a 30-day mortality (Table 4) .
DISCUSSION
Patients selected for TA-AVI are usually over 80 years and frequently with a pre-procedural compromise of renal function. In these high-risk patients, the extensive use of contrast media may lead to an increased risk of acute renal failure. The currently published literature indicates acute kidney injury between 11.7 and 57% [2] [3] [4] . The impact of the contrast medium dose on renal function and on clinical outcomes has been evaluated most extensively in patients undergoing percutaneous coronary intervention and in patients undergoing cardiac surgery. However, the effects of volume of contrast media on renal function still remain controversial. Whereas several authors consider the volume of contrast media as an independent risk factor for the development of CIN, others find no evidence of dose-related risk. Although Cigarroa et al. [5] have reported that contrast-mediated renal dysfunction occurs infrequently if the amount of a contrast agent is limited in accordance with the degree of azotaemia, the overall literature review, however, reveals disagreement as to whether the incidence of CIN is reduced by limiting the amount of a contrast agent in patients with pre-existing renal impairment [6] . Strauch et al. [3] analysed 30 patients in whom TA-AVI was performed and found that CIN developed in as many as 57% of the patients. However, they did not demonstrate any relationship between contrast amount, age, comorbid diabetes and acute kidney injury related to contrast administration. Bagur et al. [4] demonstrated that the risk of CIN in transfemoral aortic valve implantation patients was lower than in patients undergoing conventional valve replacement surgery. Interestingly, the amount of contrast media was not associated with acute kidney injury following TAVI. The fact that the mean contrast volume used in the study was <100 ml might partially explain the lack of correlation. This, in conjunction with adequate hydration and N-acetylcysteine administration, could contribute to the preservation of renal function in the postoperative period.
Regarding the amount of intra-operative contrast media, our results correlated with the findings of previous studies about percutaneous coronary intervention where an increase in CIN was found with a contrast-agent burden of >100 ml [7, 8] . A study of more than 7000 patients showed that each 100 ml of contrast medium administered correlates with a hazard ratio for CIN of 1.12 [9] . Another study limited to patients with preexisting renal disease revealed a 10-fold risk of CIN when more than 125 ml of contrast medium was administered [10] . Rather than using an absolute threshold, investigators showed that exceeding a patient-specific volume (based on body weight and serum creatinine concentration) was associated with a 12-fold 
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N. Madershahian et al. / European Journal of Cardio-Thoracic Surgeryincreased risk for haemodialysis necessitated by CIN [11] . The average of contrast injected during a standard TAVI procedure is around 100-300 ml [12] . In their large series of 270 consecutive standard TA-AVI, Van Linden et al. [13] demonstrated that postoperative acute kidney injury and renal replacement therapy depend on the amount of an intra-operative contrast agent. Regarding the amount of an intra-operative contrast agent, they could show that patients with dialysis and acute renal failure received a higher dose of a contrast agent, which was statistically significant in the renal replacement therapy group only. In both groups, the number of patients who received a contrast-agent burden of >99 ml was significantly higher. Besides thrombocytopenia and pathological leucocyte count in terms of systemic inflammatory response syndrome, Van Linden et al. identified a higher amount of contrast media as an independent risk factor for acute kidney injury. A detailed description of the causes of increased use of the contrast medium dose is quite difficult due to the retrospective study design. However, it may be assumed that the increased contrast medium may reflect cardiac complications of the procedure (i.e. coronary obstruction, myocardial infarction, inotrope usage, low cardiac output syndrome), which may have in turn induced the post-operative renal dysfunction and other complications. This potential confounding bias may be partially dealt with by analysing the post-operative serum lactate levels as an indicator for a complicated post-operative course. Interestingly, in our current clinical study, the difference between the two groups appeared to be insignificant in terms of plasma lactate levels. In our opinion, considering the steady progress that has been made over the last 4 years, the learning curve experience is surely one of the major reasons for decreasing procedural times, lower contrast medium dose and consequently lower CIN after 2008 (Table 5) . Indeed, most patients requiring increased doses of contrast medium and most of the patients who developed CIN were treated at the beginning of our TA-AVI programme. Comparing the groups in dependency of the year in which TA-AVI was performed, a significant reduction in the procedure time, amount of used contrast agent, CIN and mortality rate is seen. In consideration of the fact that pre-operative conditions did not differ over the years and moreover a higher peri-operative risk as estimated by STS score, this reduction in CIN as well as the mortality rate can possibly be explained by a procedural learning curve, also reflected by a highly significant reduction in the procedural time and a significant decreased usage of a contrast agent.
Several studies have shown CIN to be associated with increased in-hospital mortality as well as after 1 year [14, 15] and a significant independent predictor of increased mortality, length of stay and ventilator days [16] . Although we could not show any difference concerning the length of ICU or hospital stay, our study revealed a considerable higher mortality in patients receiving high doses of a contrast agent after TA-AVI.
We found arterial hypertension, coronary artery disease and the need for post-operative haemodialysis as independent risk factors for a 30-day mortality. Independent risk factors for CIN were chronic obstructive pulmonary disease and the number of blood transfusions. Surprisingly, the amount of contrast media was not an independent risk factor for CIN in our very small patient sample size. Although the analysis did not reach statistical significance (P = 0.09), however, the high amount of contrast media seems to play an important role for predicting CIN.
A larger number of blood transfusions in patients with acute kidney injury and dialysis have been reported in two studies about acute kidney injury after TAVI [2, 4] . Bagur et al. [4] described red blood cell transfusion as an additional risk factor for acute kidney injury after TAVI. This is consistent with our findings where blood transfusion was also an independent risk factor for CIN. For conventional cardiac surgery, the need for blood transfusions is a well-known predictor of acute kidney injury [17] .
In our surgical population, CIN occurred in 70% of the patients in the high-dose group, with 40% of them requiring dialysis. However, we did not find a significant difference in the need for dialysis between patients receiving high or low doses of a contrast agent, which we believe is due to the small number of patients.
Patient screening for TAVI includes cardiac catheterization routinely and CT in some of the patients. Performing those examinations during the same hospital stay and thus close to the TAVI procedure may be practical, but may also lead to an increased risk of acute kidney injury due to a higher contrast load [18] . In their recent study, Van Linden et al. [13] described no statistically significant difference with regard to the timing of cardiac catheterization and CT scan and no difference in the amount of a contrast agent given at pre-operative diagnostics. In contrast, two other studies focusing on timing of cardiac catheterization within 5 days before conventional cardiac surgery showed an increased risk for acute renal failure [19, 20] , whereas Ranucci et al. [18] showed an increased risk only when cardiac catheterization was performed on the day of surgery or within 24 h. In our study, only four patients had cardiac catheterization within 24 h prior to TA-AVI. We did not obtain CT scans routinely. Native CT scans were performed only in patients with previous cardiac surgery to define the retrosternal region for eventual urgent sternotomy. In our study, the frequency of CIN with the need of haemodialysis was significantly higher in women than in men. One large study showed that women were more likely than men to have other risk factors and that female sex remained an independent predictor of CIN, increasing the risk by 26% [21] . Sidhu et al. demonstrated that elderly women are more prone to CIN development when compared with their male peers. As their body surface is smaller than in men, the number of glomeruli in women is also smaller which results in earlier and more pronounced GFR reduction [22] .
Finally, CIN remains a common cause of renal failure in the inpatient setting and is associated with both short-and longterm adverse outcomes [23, 24] . Nevertheless, every effort has to be made to reduce the risk of CIN in TA-AVI patients by minimizing the amount of contrast media or by avoiding contrast agents (contrast dilution, contrast hand injections and echocardiography guiding for valve positioning) [25] .
LIMITATIONS
There are certain limitations to this study. The results of this study were obtained from a database with prospectively gathered data. However, this is a post hoc non-pre-specified analysis and we cannot rule out the possibility that other potential confounding variables not included in the study might have affected the results. Especially with regard to a possible influence of the general burden caused by the procedure itself and its influence on the incidence of acute post-procedural kidney injury, we cannot rule out a residual confounding, although we tried to address this as we included operation time (>120 min) as a co-variable in our univariate analysis (insignificant). In this context, we like to point out that there is a general problem with the definition of CIN in surgical patients due to the possibility of multiple co-influences. Furthermore, our findings are based on a very small sample size (especially with regard to the possibilities of statistical analysis) and clinical events from a single site, which limits generalizability to the full spectrum of patients at risk for CIN.
One main shortcoming of the present study is the missing detailed description of intra-operative data and haemodynamic parameters. The extensive use of contrast media may also reflect cardiac complications (i.e. difficulties with valve implantation) of this procedure, which may have in turn affected post-operative renal function and the patient outcome. Therefore, these shortcomings-due to the retrospective study design with the chance that other potential risk factors have not been included-limit the conclusions that can be drawn.
CONCLUSIONS
Considering the limitations of the present study, our results indicate that high-dose ionic contrast can be associated with an increased risk of CIN and death in high-risk patients (especially women) with pre-existing renal insufficiency who undergo TA-AVI. Due to the importance of preventing CIN with its increased mortality further investigation is necessary to finally understand the pathogenesis of CIN and most of all to avoid CIN and its influence of perioperative morbidity and mortality.
Madershahian et al. [1] have examined a clinically important issue-the influence of contrast media dose on adverse outcomes post-transapical aortic valve implantation (TA-AVI). The authors retrospectively examined 50 TA-AVI patients with an elevated preoperative creatinine (>1.3 mg/dl) and determined that an elevated dose of contrast media (>100 ml) was associated with higher mortality, as well as a trend towards increased intensive care unit (ICU) length of stay. Although the investigators failed to find that elevated contrast media dose was an independent predictor of mortality, this may have been due to the relatively small sample size of the study.
The described association between contrast media dose and adverse outcomes post-TA-AVI is an important finding, but not particularly surprising. Pre-existing renal impairment is a fairly common finding in TA-AVI patients. Such patients have a high incidence of congestive heart failure, peripheral vascular disease, diabetes and hypertension-all known risk factors for renal impairment. Contrast-induced nephropathy may frequently occur in such patients, particularly if they have recently undergone cardiac catheterization or computed tomography. It is for these reasons that we try to maximize the period of time between transcutaneous aortic valve procedures and preoperative contrast-based investigations in patients with pre-existing renal impairment.
Acute renal failure post-TA-AVI is a fairly common complication. A previous study from our centre revealed a 16% prevalence of acute kidney injury (AKI), defined as a decrease in estimated glomerular filtration rate of >50% in 270 TA-AVI patients [2] . Patients with AKI had increased ICU and hospital lengths of stay. In addition, AKI was an independent risk factor for in-hospital mortality (odds ratio 5.9), and 1-year survival was markedly decreased in AKI patients (45 vs. 80% in patients without AKI, P < 0.001). The administration of more than 90 ml of contrast dye during the TA-AVI procedure was an independent predictor of postoperative AKI. We concluded that contrast media dose should be minimized during TA-AVI in order to decrease the risk of postoperative renal failure.
Acute renal failure can occasionally lead to multiple complications, such as respiratory insufficiency, intubation, prolonged intensive care stay and even mortality in TA-AVI patients, probably because of their pre-existing comorbidities and reduced physiological reserve. Acute renal insufficiency post-cardiac surgery most frequently arises on postoperative days 1-3, and may occur without any recognizable preceding factors [3] . The occurrence of AKI with the abovementioned cascade of complications can be particularly vexing in patients with a heretofore completely uncomplicated TA-AVI procedure.
The main drawback of the study from Madershahian et al. [1] is the inability to determine if the relation between increased contrast media and worse post-TAVI outcomes is associative or causative. That is, was the increased contrast media dose a consequence of a complicated TAVI procedure that subsequently lead to worse outcomes, or did the contrast media in and of itself lead to renal failure and subsequent morbidity and mortality? The longer operative time in the high contrast media dose group would suggest that these patients experienced a more complicated intraoperative course, although this may also be explained by their operations being performed in the earlier part of the operators' learning curve. Unfortunately, the authors were unable to assess for other possible markers of procedure complexity including valve deployment difficulties, coronary obstruction, catecholamine requirement or low cardiac output syndrome. In addition, patients who received a higher contrast media dose had a higher risk preoperative profile, including
